Sexually transmitted diseases

Sex Transm Dis · ISSN (print) 0148-5717 · ISSN (e) 1537-4521 · 13 papers in corpus
observational 2025
doi:10.1097/olq.0000000000002184 ·PMID:40417982

BACKGROUND: Hyperosmolal lubricants may negatively affect the vaginal microenvironment, increasing the risk for bacterial vaginosis (BV). We compared the incidence of Amsel-defined BV in reproductive-age women exposed to hyperosmolal lubric…

observational 2021
doi:10.1097/olq.0000000000001434 ·PMID:34110735

BACKGROUND: Chlamydial infection is associated with tubal factor infertility (TFI); however, assessment of prior chlamydial infection and TFI is imperfect. We previously evaluated a combination of serological assays for association with TFI…

observational 2021
doi:10.1097/olq.0000000000001435 ·PMID:33833148

BACKGROUND: Nearly 14% of US women report any lifetime infertility which is associated with health care costs and psychosocial consequences. Tubal factor infertility (TFI) often occurs as a result of sexually transmitted diseases and subseq…

observational 2019
doi:10.1097/olq.0000000000000996 ·PMID:31194716

BACKGROUND: Sexually transmitted diseases, including chlamydia and gonorrhea, cause of pelvic inflammatory disease (PID) and infertility. We estimated the prevalence of infertility and infertility health care seeking. METHODS: We analyzed …

other 2013
doi:10.1097/olq.0000000000000028 ·PMID:24275724

In November 2011, the National Institutes of Health convened a workshop of basic researchers, epidemiologists, and clinical experts in pelvic inflammatory disease to identify research gaps hindering advances in diagnosis, treatment, and pre…

observational 2011
doi:10.1097/olq.0b013e3181fc6c65 ·PMID:21057380

We used 2008-2009 physician and hospital charges to estimate the direct cost of medical care per case of pelvic inflammatory disease. The estimated average total charge per episode was $3,025 (SD: $4155). The estimated average charge for pa…

rct 2010
doi:10.1097/olq.0b013e3181bc0aac ·PMID:19823111

OBJECTIVES: To evaluate safety, tolerability and systemic pharmacokinetics of escalating doses of SPL7013 Gel in healthy women. DESIGN: : Randomized, double-blind, placebo-controlled dose-escalation trial. METHODS: Thirty-seven healthy wo…

review 1998
doi:10.1097/00007435-199808000-00010 ·PMID:9713919

OBJECTIVES: To review the social and behavioral correlates of pelvic inflammatory disease (PID) in the light of the renewed interest in the transmission dynamics of communicable diseases, the new emphasis on health care seeking and health s…

observational 1992
doi:10.1097/00007435-199207000-00001 ·PMID:1411832

From 1960 10 1984, 2,501 women underwent diagnostic laparoscopy (index laparoscopy) because of a clinical suspicion of acute pelvic inflammatory disease (PID). Of these women, 1,844 had abnormal laparoscopic findings (patients) and 657 had …

observational 1992
doi:10.1097/00007435-199201000-00006 ·PMID:1561585

In order to explore possible etiologic differences between tubal infertility in women who had been physician-diagnosed as having pelvic inflammatory disease ("overt" PID) and in women who had not ("silent" pelvic inflammatory disease), we m…

other 1991
doi:10.1097/00007435-199101000-00011 ·PMID:2028368
nonrandomized-trial 1989
doi:10.1097/00007435-198904000-00003 ·PMID:2740961

Chlamydia trachomatis infections in pregnancy are associated with a high rate of transmission to the newborn and may be associated with poor obstetrical outcome including low birth weight, premature delivery, stillbirth and neonatal death. …

other 1979
doi:10.1097/00007435-197907000-00009 ·PMID:116375